메뉴 건너뛰기




Volumn 94, Issue 16, 2002, Pages 1184-1185

The need for and characteristics of randomized, phase III trials to evaluate symptom management in patients with cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;

EID: 0037151386     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.16.1184     Document Type: Editorial
Times cited : (26)

References (8)
  • 1
  • 8
    • 0005331339 scopus 로고    scopus 로고
    • Symptom management in cancer: Pain, depression, and fatigue
    • National Institutes of Health Consensus Development Program. Draft statement. State-of-the Science Conference, July 15-17, 2002. [Last accessed: 7/23/02.] Available at:


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.